These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3910496)

  • 1. Biological potency of porcine, bovine and human insulins in the rabbit bioassay system.
    Pingel M; Vølund A; Sørensen E; Collins JE; Dieter CT
    Diabetologia; 1985 Nov; 28(11):862-9. PubMed ID: 3910496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Health Organization International Standards for highly purified human, porcine and bovine insulins.
    Bristow AF; Das RE; Bangham DR
    J Biol Stand; 1988 Jul; 16(3):165-78. PubMed ID: 3049614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radioreceptor assay for pharmaceutical preparations of insulin.
    Baxter D
    J Biol Stand; 1986 Oct; 14(4):319-30. PubMed ID: 3549735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of porcine and semisynthetic human insulins using euglycemic clamp-derived glucose-insulin dose-response curves in insulin-dependent diabetes.
    Staten M; Worcester B; Szekeres A; Waldeck N; Ascher M; Walsh KM; Rizza R; Gerich J; Charles MA
    Metabolism; 1984 Feb; 33(2):132-5. PubMed ID: 6363874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the biologic activity of porcine and semisynthetic human insulins using the glucose-controlled insulin infusion system in insulin-dependent diabetes.
    Szekeres A; Worcester B; Ascher MS; Tuxen D; Heyendal R; Walsh KM; Charles MA
    Diabetes Care; 1983; 6(2):193-6. PubMed ID: 6343025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The determination of the biological activity of insulin by a radioreceptor method].
    Dimitrova E; Sirakov L
    Eksp Med Morfol; 1993; 31(3-4):72-86. PubMed ID: 7805622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human insulin (Novo): chemistry and characteristics.
    Markussen J; Damgaard U; Pingel M; Snel L; Sørensen AR; Sørensen E
    Diabetes Care; 1983; 6 Suppl 1():4-8. PubMed ID: 6343036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response to infusions of highly purified and conventional bovine and porcine insulins.
    Nosadini R; Noy G; Kurtz AB; Alberti KG
    Diabetes; 1981 Aug; 30(8):650-5. PubMed ID: 7018969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the euglycaemic clamp technique to bioassay of insulin analogues.
    Vłlund A; Ribel U; Dam PL; Markussen J; Langkjaer L; Dolben J; Owens DR
    Biologicals; 1992 Jun; 20(2):135-42. PubMed ID: 1389109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of potency of porcine insulin and semisynthetic human insulin at 3 dose levels using the euglycaemic clamp.
    Chisholm DJ; Kraegen EW; Hewett MJ; Lazarus L
    Horm Metab Res; 1983 Sep; 15(9):415-8. PubMed ID: 6357983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation of human, bovine, and porcine insulins, three very closely related proteins, by micellar electrokinetic chromatography.
    Lamalle C; Roland D; Crommen J; Servais AC; Fillet M
    Electrophoresis; 2015 Oct; 36(19):2504-6. PubMed ID: 26095856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular structural changes in rabbits on treatment with bovine and porcine insulin. A morphometric analysis.
    Wehner H; Eiche T; Eiche F; Heding LG
    Virchows Arch A Pathol Anat Histol; 1980; 389(2):211-23. PubMed ID: 7006198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin to normal man.
    Owens DR; Jones MK; Birtwell AJ; Burge CT; Jones IR; Heyburn PJ; Hayes TM; Heding LG
    Horm Metab Res; 1984 Dec; 16 Suppl 1():195-9. PubMed ID: 6152435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control.
    Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG
    Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate bioassay.
    Vølund A
    Biometrics; 1980 Jun; 36(2):225-36. PubMed ID: 6996751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthetic human insulin: pharmacokinetics and biological potency in healthy subjects in comparison with highly purified porcine insulin.
    Schulz B; Stöwhas H; Becker R; Steinicke A; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):307-13. PubMed ID: 3075554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the activity and pharmacokinetics of porcine insulin and human insulin (Novo) as assessed by the glucose clamp technique in normal and diabetic man.
    Home PD; Shepherd GA; Noy G; Massi-Benedetti M; Hanning I; Burrin JM; Alberti KG
    Diabetes Care; 1983; 6 Suppl 1():23-8. PubMed ID: 6343033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of porcine and human isophane (NPH) insulins in normal subjects.
    Owens DR; Jones IR; Birtwell AJ; Burge CT; Luzio S; Davies CJ; Heyburn P; Heding LG
    Diabetologia; 1984 Apr; 26(4):261-5. PubMed ID: 6376233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.